Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer (2022)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; LEITE, KATIA RAMOS MOREIRA - FM
- Unidade: FM
- DOI: 10.1016/j.acuro.2020.11.012
- Subjects: CROMOSSOMOS HUMANOS; NEOPLASIAS PROSTÁTICAS; FENÓTIPOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Actas urologicas espanolas
- ISSN: 0210-4806
- Volume/Número/Paginação/Ano: v. 46, n. 2, p. 78-84, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ROMAO, P et al. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer. Actas urologicas espanolas, v. 46, n. 2, p. 78-84, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.acuro.2020.11.012. Acesso em: 02 jan. 2026. -
APA
Romao, P., Souza, I. de C., Silva, I., Guimaraes, V. R., Camargo, J. A. de, Santos, G. A. dos, et al. (2022). Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer. Actas urologicas espanolas, 46( 2), 78-84. doi:10.1016/j.acuro.2020.11.012 -
NLM
Romao P, Souza I de C, Silva I, Guimaraes VR, Camargo JA de, Santos GA dos, Viana NI, Srougi M, Leite KRM, Reis ST, Pimenta R. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer [Internet]. Actas urologicas espanolas. 2022 ; 46( 2): 78-84.[citado 2026 jan. 02 ] Available from: https://doi.org/10.1016/j.acuro.2020.11.012 -
Vancouver
Romao P, Souza I de C, Silva I, Guimaraes VR, Camargo JA de, Santos GA dos, Viana NI, Srougi M, Leite KRM, Reis ST, Pimenta R. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer [Internet]. Actas urologicas espanolas. 2022 ; 46( 2): 78-84.[citado 2026 jan. 02 ] Available from: https://doi.org/10.1016/j.acuro.2020.11.012 - PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Treating metastatic prostate cancer with microRNA-145
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- GLUT1 expression is related to tumor recurrence and survival in renal cell carcinoma clear cell type
- Comprehensive study of gene and microRNA expression related to epithelial-mesenchyamal transition in prostate cancer
- Expression of miRNAs 200c and 33a That Negatively Control HAS2 and HAS3 in Localized Prostate Cancer
- Genetic alterations related to Cystinuria – a genome wide assocaition analysis
- Micro RNA 100, 145 and 373 in prostate cancer: From gene regulation to apoptosis
- Micro RNAs and Androgen Receptor in Prostate Cancer
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
Informações sobre o DOI: 10.1016/j.acuro.2020.11.012 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
